Cardiovascular Pharmacotherapy in Women

Acces the course platform.

Access the course platform via the button below for on demand content.

Please note access only for regstistred participants. 

Course platform

Programme

All sessions include 10–15 minutes of discussion time with the expert faculty.

Download the programme

Join the ESC Working Group on Cardiovascular Pharmacotherapy

To find out more, benefit from savings, and get updates about the field of cardiovascular pharmacotherapy, join the Working Group now.

Membership is free.

Who should attend

Reducing cardiovascular disease burden by pharmacotherapy represents a major challenge that requires specific knowledge and expertise. A multistep approach to the problem is needed to gain insight into the following key areas of knowledge.

Regarding defined patient groups in whom pharmacotherapy has specific requirements, women feature prominently. Marked knowledge gaps exist in relation to cardiovascular pharmacotherapy in women mainly associated to the fact that treatments are often extrapolated from those that have been shown to be mainly effective in men, dosing is often inappropriate as sparse data exist in the literature regarding gender differences in response to pharmacotherapy due to poor representation of women in clinical trials. Gender-specific risk factors are often ignored or neglected.

Healthcare professionals responsible for the care of women with cardiovascular conditions, as well as trainees aiming to enter these fields, will benefit from this educational training course.

Learning objectives

Complementary to the All About Clinical Trials course, and the Pharmacotherapy in Older People course, the Cardiovascular Pharmacotherapy in Women course aims to improve the competency and confidence of participants in:

• Bridging knowledge gaps regarding cardiovascular treatment and risk assessment of female patients
• The assessment of both cardiovascular risk and the effect of pharmacotherapy in women
• Identifying enablers and barriers in the management of female patients with cardiovascular conditions
• The management of women-specific issues related to cardiovascular pharmacotherapy

Scientific Committee and Course Format

Conference scientific committee

• Prof. Juan Carlos Kaski – Course Director
• Prof. Anne Gret Semb – Course Co-director

Format

The course will be delivered online, over two half days (from approx. 13:00–18:00 each day).

The sessions will be made available on demand for one month after course, to registered delegates (although in order to claim CME Credits, you will need to watch the sessions live).

Faculty

Learn directly from the world-renowned experts in the field!

Confirmed faculty include :

Marianna Adamo

• Rasha Al-Lamee
• Noel Bairey Merz
• Iris Baumgartner
• Colin Berry
• Lina Bidamon
• Claudio Borghi
• Barry Borlaug
• Claudio Ceconi
• Elisabetta Cerbai
• Renata Cifkova
• Gheorghe-Andrei Dan
• Geneviève Derumeaux
• Dobromir Dobrev
• Heinz Drexel
• Ian Graham
• Martha Gulati
• Sigrun Halvorsen
• Juan Carlos Kaski
• Kalliopi Keramida
• Maddalena Lettino
• Basil S Lewis
• Angela Maas
• Marco Metra
• Helga Midtø
• Maria Lorenza Muiesan
• Alexander Niessner
• Eva Prescott
• Vera Regitz-Zagrosek
• Mercedes Roque
• Giuseppe MC Rosano
• Gianluigi Savarese
• Anne Grete Semb
• Karen Sliwa
• Patrick Sulzgruber
• Juan Tamargo
• Viviani Taqueti
• Maria Tektonidou
• Lale Tokgozoglu
• Christian Torp-Pedersen

CME accreditation

The ESC submits its educational programmes (including online programmes) to the UEMS-EACCME for accreditation. The European Accreditation Council for Continuing Medical Education (EACCME) is an institution of the European Union of Medical Specialists (UEMS) responsible for the evaluation and accreditation of Medical Education Programmes.

Annual training programme of the ESC Working Group on Cardiovascular Pharmacotherapy

This course is part of an annual training programme designed to provide insight into the following key areas:

• The identification of new potentially effective pharmacological agents
• The effective testing of new pharmacological compounds in the clinical setting
• The complexities of regulatory approval
• The safe and efficient implementation of cardiovascular pharmacotherapy in clinical practice
• The specific needs of different patient groups i.e., older individuals and women
• Understanding the current unmet needs regarding pharmacotherapy and assessing and implementing evidence-based recommendations

Other courses include the All About Clinical Trials course and the Pharmacotherapy in Older People course.

Learn more.